| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.82M | -50,000 | |
| CEO | 2.07M | $8.08M | - | |
| Dir | 1.48M | $5.76M | - | |
| CFO | 1.07M | $4.18M | - | |
| Other | 1.04M | $4.07M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 55,330 | $6.47 | $357,900.45 | - | +51.6% | -20.0% | |
| Apr 29, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 80,675 | $6.14 | $495,381.25 | - | +33.4% | -23.1% | |
| Apr 22, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 80,108 | $6.17 | $494,275.02 | - | +41.5% | -4.7% | |
| Apr 18, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 38,336 | $6.83 | $261,841.92 | - | +22.8% | -9.0% | |
| Apr 14, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 37,017 | $7.55 | $279,630.13 | - | +9.0% | -20.4% | |
| Apr 8, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 39,420 | $6.60 | $259,991.26 | - | +35.2% | -2.0% | |
| Apr 7, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 39,218 | $6.54 | $256,519.87 | - | +35.0% | -0.6% | |
| Apr 6, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 38,326 | $6.76 | $259,118.73 | - | +33.1% | 0.0% | |
| Apr 5, 2022 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 36,972 | $7.43 | $274,517.73 | - | +24.3% | -9.4% | |
| Mar 15, 2022 | Christopher Gibson71 | Chief Executive Officer | Sell | 336,150 | $6.48 | $2,176,801.38 | -59.0% | -7.2% | +19.7% |